Perception Axeron AI·Early access

Biotech research workspace

Public biotech evidence in one place, every claim cited.

Perception reads SEC filings, ClinicalTrials.gov, PubMed and openFDA for the biotech companies it covers, tracks their upcoming catalysts, and answers questions with a citation for each statement.

Sign in or request access

Access is by approval during early access. After you create an account, an Axeron operator reviews it; you can sign in once it is approved.

Sources

SEC EDGAR filings, ClinicalTrials.gov registry records, PubMed abstracts and openFDA records, collected for the biotech companies Perception covers.

Catalysts

Trial readouts, PDUFA dates disclosed in filings and scheduled earnings, each linked to the record it came from.

Answers

Questions are answered from the collected evidence only. Each statement links to its source; when the evidence is thin, the answer says so.

Your workspace

Each account is its own workspace. What you write is never visible to another account.